The Fate of Nasally Administered Antibodies: Olfactory & Trigeminal Pathways to the Brain & Delivery to the Lymphnodes & Circulation
Time: 11:30 am
day: Conference Day One
Details:
- Delving into strategies for crafting particles that are not only smaller but precisely tailored to enable API bypass of the blood-brain barrier when delivered to the upper nasal cavity
- Sharing best practices to assess and maintain the desired particle size for delivery to the brain
- Reducing additional challenges, including prolonging mucosal retention time, enhancing penetration through nasal epithelia, and limiting premature drug metabolism
